07/03/2019. Jan Ramaekers spoke to Sander Hoogendoorn in his 3FM morning broadcast on the decision of the FDA to approve a ketamine derived depression drug. Listen to podcast (at 1h51m) here
07/03/2019. Jan Ramaekers spoke to Sander Hoogendoorn in his 3FM morning broadcast on the decision of the FDA to approve a ketamine derived depression drug. Listen to podcast (at 1h51m) here